Minerva Neurosciences, Inc. Earnings Per Share, Basic and Diluted
Minerva Neurosciences, Inc. (NERV) reported Earnings Per Share, Basic and Diluted of -$1.63 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-09
- Minerva Neurosciences, Inc. earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$1.63.
- Minerva Neurosciences, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.23.
- Minerva Neurosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.98.
- Minerva Neurosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.21.
- Minerva Neurosciences, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.85.
- Minerva Neurosciences, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.29.
- Minerva Neurosciences, Inc. earnings per share, basic and diluted for fiscal 2017 was -$0.83.
- Minerva Neurosciences, Inc. earnings per share, basic and diluted for fiscal 2016 was -$0.99.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$1.63 10-Q · filed 2022-08-09 | -$3.46 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | -$0.23 10-Q · filed 2022-05-04 | |||
| 2021-06-30 | -$1.98 10-Q · filed 2022-08-09 | -$3.63 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$0.21 10-Q · filed 2022-05-04 | |||
| 2020-03-31 | -$0.31 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | -$1.85 10-K · filed 2020-03-09 | |||
| 2019-09-30 | -$0.36 10-Q · filed 2019-11-04 | -$1.08 10-Q · filed 2019-11-04 | ||
| 2019-06-30 | -$0.32 10-Q · filed 2019-08-05 | -$0.73 10-Q · filed 2019-08-05 | ||
| 2019-03-31 | -$0.41 10-Q · filed 2020-05-04 | |||
| 2018-12-31 | -$1.29 10-K · filed 2020-03-09 | |||
| 2018-09-30 | -$0.31 10-Q · filed 2019-11-04 | -$0.95 10-Q · filed 2019-11-04 | ||
| 2018-06-30 | -$0.32 10-Q · filed 2019-08-05 | -$0.64 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | -$0.32 10-Q · filed 2019-05-06 | |||
| 2017-12-31 | -$0.83 10-K · filed 2019-03-12 | |||
| 2017-09-30 | -$0.28 10-Q · filed 2018-11-05 | -$0.84 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | -$0.27 10-Q · filed 2018-08-02 | -$0.57 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | -$0.30 10-Q · filed 2018-05-03 | |||
| 2016-12-31 | -$0.99 10-K · filed 2018-03-12 | |||
| 2016-09-30 | -$0.24 10-Q · filed 2017-11-06 | -$0.71 10-Q · filed 2017-11-06 | ||
| 2016-06-30 | -$0.18 10-Q · filed 2017-08-03 | -$0.47 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | -$0.29 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | -$1.16 10-K · filed 2018-03-12 | |||
| 2015-09-30 | -$0.24 10-Q · filed 2016-11-03 | -$0.81 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | -$0.27 10-Q · filed 2016-08-04 | -$0.58 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | -$0.31 10-Q · filed 2016-05-03 | -$0.71 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$2.19 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$3.80 derived: net income ÷ weighted average shares · filed 2017-03-13 |
| 2014-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$1.91 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$3.69 derived: net income ÷ weighted average shares · filed 2017-03-13 | -$4.47 10-K · filed 2017-03-13 |
| 2014-09-30 | -$1.53 10-Q · filed 2015-11-05 | -$3.67 derived: net income ÷ weighted average shares · filed 2015-11-05 | -$4.58 10-Q · filed 2015-11-05 | -$5.51 derived: net income ÷ weighted average shares · filed 2015-11-05 |
| 2014-06-30 | -$2.55 10-Q · filed 2015-08-05 | -$3.07 10-Q · filed 2015-08-05 | -$3.72 derived: net income ÷ weighted average shares · filed 2015-08-05 | -$4.19 derived: net income ÷ weighted average shares · filed 2015-08-05 |
| 2014-03-31 | -$0.43 10-Q · filed 2015-05-07 | -$0.84 derived: net income ÷ weighted average shares · filed 2015-05-07 | -$1.03 derived: net income ÷ weighted average shares · filed 2015-05-07 | -$1.18 derived: net income ÷ weighted average shares · filed 2015-05-07 |
| 2013-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2015-03-26 | -$0.56 derived: net income ÷ weighted average shares · filed 2015-03-26 | -$0.68 derived: net income ÷ weighted average shares · filed 2015-03-26 | -$0.78 10-K · filed 2015-03-26 |
| 2013-09-30 | -$0.12 10-Q · filed 2014-11-06 | -$0.22 derived: net income ÷ weighted average shares · filed 2014-11-06 | -$0.29 10-Q · filed 2014-11-06 | |
| 2013-06-30 | -$0.10 10-Q · filed 2014-08-07 | -$0.17 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |